Meeting category
Date(s)
21 Jul 2017 - 22 Jul 2017
Location
Paris,
France
Titanium Level Support
Sponsor logos
International Workshop on HIV Transmission 2017
Related Enduring Materials
Enduring Materials
Day 1 - Friday, 21 July 2017
Session 1: Prevention strategies -
Chairs
Vaccine induced susceptibility vs protection
Abstract presentations
Identification of rapid and emerging transmission clusters from genetic network
Tsz Ho Kwa
Jockey Club School Of Public Health And Primary Care, The Chinese University Of Hong Kong, Hong Kong
Phylogenetic, epidemiological and virological insights on the rise of large cluster outbreaks fueling the HIV-1 epidemic among Men having sex with Men within Quebec
A novel NRTI, EFdA, effectively penetrates and suppresses HIV infection in all individual compartments of male genital tract (not available)
Martina Kovarova
University Of North Carolina At Chapel Hill, USA
Session 2: Blocking HIV Transmission -
Chairs
Stacy Carrington-Lawrence, PhD
NIH, USA
Passive antibody to block transmission
Abstract presentations
A Combination of Broadly Neutralizing Antibodies Prevents In Vitro SHIV162P3 Cell-Free Transmission More Efficiently Than Cell-to-Cell Transmission (not available)
Karunasinee Suphaphiphat
CEA, France
Broadly neutralizing antibody against HIV-1 Env blocks infection of the first cell after mucosal challenge of macaques (not available)
Christiane Stahl-Hennig
Deutsches Primatenzentrum GmbH, Germany
Non-neutralizing Antibodies Targeting HIV’s V1V2 Domain Exhibit Strong Inhibitory Activities (not available)
Luzia Mayr
Inserm U1109, France
Session 3: Round table discussion: Making PrEP a success -
Chairs
Gina Brown, MBBS, MD, MRCP, FRCR, FASCRS (Hon)
Imperial College London, UK
Making PrEP a succes
Behaviour perspective
Abstract presentation
New formulation of injectable and removable long-acting dolutegravir is effective in prevention of HIV transmission with high dose vaginal HIV challenges (not available)
Martina Kovarova
University Of North Carolina At Chapel Hill, USA
Guided Poster Tour -
Chairs
Gina Brown, MBBS, MD, MRCP, FRCR, FASCRS (Hon)
Imperial College London, UK
Evaluating the feasibility of implementing UNAIDS' 90 90 90 strategy, achieving universal access to treatment, and eliminating HIV in Malawi
Laurence Palk
University Of California, Los Angeles, USA
OLA-Simple 1.0: Laboratory Kit for HIV Drug Resistance Testing in Low-Resource Settings
Nuttada Panpradist
University Of Washington, USA
Couples HIV Testing and Counseling for Heterosexual Pregnant Women and their Partners Seeking Prenatal Care in Philadelphia, PA
Itoro Inoyo
Drexel University College of Medicine, Division of Infectious Diseases & HIV Medicine, USA
An HIV Risk Assessment Tool to Predict HIV Transmission within HIV Serodiscordant Couples
Kristin Wall
Emory University, USA
Day 2 - Saturday, 22 July 2020
Session 4: Early events of HIV Transmission -
Chairs
Trafficking of HIV out of the mucosa
Defining the first phases of penetration and infection of HIV/SIV into the mucosal tissues
Camille Ducloy
Inserm UMR 1109, France
Intestinal Dendritic Cells and Macrophages Play a Different Role in the Early Events of HIV-1 Transmission.
Mariangela Cavarelli
Cea, France
The impact of specific N-linked glycosylation patterns on HIV-1 transmission fitness
Katja Klein
University Of Western Ontario, Canada
Session 5: Post Transmission Events -
Chairs
Abstract-driven presentations
Gut Dysbiosis During Acute HIV Infection
Angela Wahl
University Of North Carolina At Chapel Hill,US
HIV-1 Vif adaptation to host immune pressure impact of cytidine deaminases and host HLA.
Deep sequencing reveals viral evolution in Gag within protective HLA alleles B*57:02, B*58:01 and B*7 supertype individuals acutely infected with HIV-1 subtype C in Durban, South Africa
Kamini Gounder
Hiv Pathogenesis Programme, University Of Kwa-zulu Natal, South Africa
Unexpected antibody isotypes and neutralizing profile in patients controlling HIV
Jéromine Klingler
Inserm Umr_s 1109, Francexx
Transmitted drug-resistance in newly diagnosed HIV drug-naïve individuals in Portugal
Session 6: Round table discussion: Using transmission networks for targeted interventions -
Chairs
Introduction: Using transmission networks for targeted interventions
Overview
Over the years, advances in HIV treatment have led to an enhanced understanding of the virus and improved care of HIV infected patients. However our insights into the spread of the HIV virus remain limited. A more extensive exchange of knowledge on the various aspects of HIV transmission provides important perspectives for a better approach to the epidemic. For this purpose, an integrated forum was set up in 2006 to reveal perspectives of experts from different fields enabling discussion on all relevant mechanisms of HIV transmission. The annual Transmission Workshops have since continued to prove themselves valuable to those specialized (or specializing) in HIV transmission.
The main objectives of this meeting are to provide a forum for basic scientists, clinicians, virologists, epidemiologists and public health officials to present and to discuss the various aspects of the transmission of HIV. The ultimate goal of the meeting is the integration of efforts from all relevant disciplines in order to constrain the spread of (drug-resistant) HIV.
General Information
Meeting Objectives
This meeting aims to:
- Enhance the integration of all relevant disciplines to constrain the spread of (drug-resistant) HIV;
- Provide a forum to discuss the various aspects of the transmission of HIV.
- Enhance the integration of all relevant disciplines to constrain the spread of (drug-resistant) HIV;
- Provide a forum to discuss the various aspects of the transmission of HIV.
Learning Objectives
After participating in this activity, participants will be able to:
- Describe the latest research on mucosal transmission of virus particles;
- Outline the different approaches to identify the spread of (drug-resistant) HIV variants;
- Reflect on clinical achievements in the prevention of HIV transmission.
- Describe the latest research on mucosal transmission of virus particles;
- Outline the different approaches to identify the spread of (drug-resistant) HIV variants;
- Reflect on clinical achievements in the prevention of HIV transmission.
Practical Information
Language
The official language of the workshop was English.
Translation was not provided.
Translation was not provided.
Disclaimer
This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this workshop, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this workshop. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop.
Liability and Insurance
By registering for the workshop participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official workshop sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
Committees
Organizing Committee
The members of the Organizing Committee (OC) discuss, on a frequent basis, the scientific program of the workshop, identify interesting topics and candidate speakers and review all submitted abstracts.
Scientific Committee
The members of Scientific Committee assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.
- Stephen Becker, MD - Bill & Melinda Gates Foundation, USA
- Sally Blower, PhD - University of Los Angeles, USA
- Max Essex, PhD - Harvard T.H. Chan School of Public Health, USA
- Robert Grant, MD, PhD - University of California, USA
- Yasmin Halima, MPH - EQUIP/ Right to Care, South Africa
- David Hawkins, MD - Chelsea and Westminster Hospital UK
- Sharon Hillier, PhD - Magee Womens Hospital UPMC, USA
- Patrick Kiser, PhD - Northwestern University, USA
- Roger Legrand, Commissariat á l'Energie Atomique, France
- Susan Little, MD - University of California, USA
- Sheena McCormack, MD - MRC Clinical Trials Unit, United Kingdom
- Michaela Müller-Trutwin - Pasteur Institute, France
- Jim Mullins, PhD - University of Washington, USA
- Helen Rees, MD - University of the Witwatersrand, Johannesburg, South Africa
- Merlin Robb - Henry M. Jackson Foundation, USA
- Asier Siron Saez - Pasteur Institute, France
- Robin Shattock - Imperial College, UK
- Christiane Stahl-Hennig, Deutsches Primatenzentrum GmbH, Germany
Support
Titanium Level
Endorsers
Language
Related Programs
